Bioactivity of natriuretic peptide coinfusions; no evidence for unique effects of BNP in conscious sheep

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 2, 1999, Pages 229-236

  Charles, Christopher J ^a   Espiner, Eric A ^a   Nicholls, M Gary ^a   Rademaker, Miriam T ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Arterial pressure; Cardiac output; Cyclic GMP; Natriuresis

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYCLIC GMP; HYDROCORTISONE; POTASSIUM; RENIN; SODIUM;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HEART OUTPUT; HEART RATE; HEMATOCRIT; INTRAVENOUS DRUG ADMINISTRATION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; CARDIAC OUTPUT; CYCLIC GMP; DIURESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEART RATE; HEMATOCRIT; NATRIURESIS; NATRIURETIC PEPTIDE, BRAIN; SHEEP; URINALYSIS;

EID: 0032959516     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199902000-00008     Document Type: Article

References (24)

1. Cheung BMY, Dickerson JEC, Ashby MJ, Brown MJ, Brown J. Effects of physiological increments in human α-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects. Clin Sci 1994;86:723-30.
2. Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 1995;24:481-509.
3. Lang CC, Choy AMJ, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci 1982;83:519-27.
4. Suga S, Nakao K, Hosoda M, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130:229-39.
5. Ruskoaho H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev 1992;44:479-602.
6. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 1994; 266:R1244-50.
7. Hunt PJ, Espiner EA, Richards AM, Yandle TG, Frampton C, Nicholls MG. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal man. Am J Physiol 1995; 269:R1397-403.
8. Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J Clin Endocrinol Metab 1996; 81:3871-6.
9. Pidgeon GB, Richards AM, Nicholls MG, Espiner EA, Yandle TG, Frampton C. Differing metabolism and bioactivity of atrial brain natriuretic peptides in essential hypertension. Hypertension 1996; 27:906-13.
10. Charles CJ, Espiner EA, Nicholls MG, et al. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol 1996;271:R373-80.
11. Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM. Comparative bioactivity of atrial and brain natriuretic peptide in an ovine model of heart failure. Clin Sci 1997; 92:159-65.
12. Rademaker MT, Charles CJ, Kosoglou T, et al. Clearance receptors and endopeptidase 24.11 contribute equally to natriuretic peptide metabolism in an ovine model of heart failure. Am J Physiol 1998; 41:H2372-9.
13. Aitken GD, George P, Espiner EA. Characterisation of ovine natriuretic peptide genomic DNA sequences [Abstract]. J Hypertens 1994;12(suppl 3):S174.
14. Charles CJ, Espiner EA, Cameron VA, Richards AM. Hemodynamic, renal, and endocrine actions of ANF in sheep: effect of 24-h, low-dose infusions. Am J Physiol 1990;258:R1279-85.
15. Yandle TG, Aitken GD, Fisher SF, Rademaker M, Espiner EA, Nicholls MG. Ovine brain natriuretic peptide: identity, measurement, and regulation [Abstract]. J Hypertens 1994;12(suppl 3): S50.
16. Lun S, Espiner EA, Nicholls MG, Yandle TG. A direct radioimmunoassay for aldosterone in plasma. Clin Chem 1983;29:268-71.
17. Dunn P, Espiner EA. Outpatient screening tests for primary aldosteronism. Aust NZ J Med 1976;6:131-5.
18. Lewis JG, Manley L, Whitlow JC, Elder PA. Production of a monoclonal antibody to cortisol: application to a direct immunosorbent assay of plasma. Steroids 1992;57:82-5.
19. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Sybertz E, Frampton CM. Low dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition. Clin Sci 1997;92:255-60.
20. Charles CJ, Espiner EA, Richards AM, Nicholls MG, Yandle TG. Comparative bioactivity of atrial, brain and C-type natriuretic peptides in conscious sheep. Am J Physiol 1996;270:R1324-31.
21. Moe GW, Grima EA, Wong NLM, Howard RJ, Armstrong PW. Dual natriuretic peptide system in experimental heart failure. J Am Coll Cardiol 1993;22:891-8.
22. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
23. Maack T, Okolicany J, Koh GY. Functional properties of atrial natriuretic factor receptors. Semin Nephrol 1993;13:50-60.
24. Kenny AJ, Bourne A, Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J 1994;291: 1428-35.